This article explores the patent landscape in more detail, and looks at how the information gleaned from the analysis of a patent landscape can provide a company important insights to better understand their place in a given market space and help to make strategic decisions.
Founded as a NASA JV to help companies harness the tremendous IT and IP from the Apollo Program, we’ve helped organizations affect high-impact innovation collaborations ever since. Click here to see ways Nerac can help you affect collaborative SDG strategies, ecosystems and ICT-enabled innovations for new “giant leaps” that benefit mankind and shareholders alike.
While clinical data is required for manufacturers of high risk devices and implants, the vast majority of manufacturers that make low-to-medium risk devices may not need to conduct clinical trials for their products or produce peer-reviewed literature that supports their clinical use. This article helps identify the specific clauses of the guidance document that pertain to clinical data and explores alternative pathways to compliance.